Drug recall · February 12, 2014
Dr. Reddy's Metoprolol Succinate Extended-Release Tablets USP recall
Why: Failed Dissolution Specification; 12-Month stability interval.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dr. Reddy's Metoprolol Succinate Extended-Release Tablets USP, 50 mg 100 tablets Rx Only Mfd. By: Dr. Reddy's Laboratories Limited Bachepalli -500 090 INDIA NDC 55111-467-01
- Lots / codes
Lot # C207420 and C207416
- Quantity
- 8,592 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- LA, MI, MO, MS & OH
- Initiated
- December 13, 2013 · Voluntary: Firm initiated
- Classified
- February 6, 2014
- Reported
- February 12, 2014
- Ended
- February 12, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.